# FDA Inspection 1121637 - CSL Behring AG - February 18, 2020

Source: https://www.globalkeysolutions.net/records/fda_inspections/csl-behring-ag/efbc8f3e-ac1a-4bf9-95eb-afb9f2185271
Source feed: FDA_Inspections

> FDA Inspection 1121637 for CSL Behring AG on February 18, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1121637
- Company Name: CSL Behring AG
- Inspection Date: 2020-02-18
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1057840 - 2018-04-13](https://www.globalkeysolutions.net/records/fda_inspections/csl-behring-ag/f926487f-2e44-4432-98c7-9602dc241d81)
- [FDA Inspection 990288 - 2016-09-29](https://www.globalkeysolutions.net/records/fda_inspections/csl-behring-ag/bf71c67d-2ad1-4213-afc2-309d6dadc636)
- [FDA Inspection 890258 - 2014-06-19](https://www.globalkeysolutions.net/records/fda_inspections/csl-behring-ag/d0465f7f-9340-432d-bce2-3d4c437cd2f8)
- [FDA Inspection 769044 - 2012-02-02](https://www.globalkeysolutions.net/records/fda_inspections/csl-behring-ag/db3edea9-55a8-4577-8ca4-6386b53e1214)
- [FDA Inspection 645082 - 2010-01-19](https://www.globalkeysolutions.net/records/fda_inspections/csl-behring-ag/7f66df73-371f-448a-a090-eaa3dda7a537)

Company: https://www.globalkeysolutions.net/companies/csl-behring-ag/e5513eac-b911-45b6-b707-dae3d0376210

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
